Cited by 60Cardiac Arrhythmias and TreatmentsAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Persistent Atrial Flutter in Patients Treated for Atrial Fibrillation with Amiodarone and Propafenone: Electrophysiologic Characteristics, Radiofrequency Catheter Ablation, and Risk Prediction

TAI, CHING‐TAI, CHIANG, CHERN‐EN, LEE, SHIH‐HUANG, CHEN, YI‐JEN, YU, WEN‐CHUNG, FENG, AN‐NING, DING, YU‐AN, CHANG, MAU‐SONG +1 more·1999·Journal of Cardiovascular Electrophysiology

Abstract

INTRODUCTION: Antiarrhythmic drugs have been reported to promote the conversion of atrial fibrillation to atrial flutter in patients with paroxysmal atrial fibrillation. However, information about the electrophysiologic mechanism and response to radiofrequency ablation of these drug-induced atrial flutters is limited. Furthermore, the determinants of the development of persistent atrial flutter in patients treated for atrial fibrillation with antiarrhythmic drugs are still unknown. METHODS AND RESULTS: Among the 136 patients treated for atrial fibrillation with amiodarone (n = 96) or propafenone (n = 40), 15 (11%, mean age 65.5 +/- 12.3 years) were identified to have subsequent development of persistent atrial flutter based on surface ECG characteristics during antiarrhythmic drug treatment. The mean interval between the beginning of drug treatment and the onset of atrial flutter was 5.0 +/- 5.5 months. Intracardiac mapping and entrainment studies revealed that 11 patients had counterclockwise typical atrial flutter, and 4 had clockwise typical atrial flutter. All 15 patients underwent successful ablation with creation of complete bidirectional isthmus conduction block. After a mean follow-up of 12.3 +/- 4.2 months, 14 (93%) of 15 patients who underwent successful ablation and continued taking antiarrhythmic drugs have remained in sinus rhythm. Univariate analysis of clinical variables demonstrated that only atrial enlargement was significantly related to the occurrence of persistent atrial flutter. CONCLUSION: In patients with atrial fibrillation, persistent typical atrial flutter might occur during antiarrhythmic drug treatment, and atrial enlargement was a risk factor for the development of such an arrhythmia. Radiofrequency ablation and continuation of pharmacologic therapy offered a safe and effective means of achieving and maintaining sinus rhythm.

Integrity signals

Registry

Crossref · 10.1111/j.1540-8167.1999.tb00293.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Combining cavotricuspid isthmus ablation and antiarrhythmic drugs may lead to improved rhythm control without the need for left atrial ablation in patients who develop 'drug-induced atrial flutter' on therapy with flecainide, propafenone, or amiodarone.

    “Combining cavotricuspid isthmus ablation and antiarrhythmic drugs may lead to improved rhythm control without the need for left atrial ablation in patients who develop 'drug-induced atrial flutter' on therapy with flecainide, propafenone, or amiodarone, [834][835][836]”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
TAI, C., CHIANG, C., LEE, S., CHEN, Y., YU, W., FENG, A., DING, Y., CHANG, M., & CHEN, S.
Affiliations
  • Taipei Veterans General Hospital (TW)
  • Shin Kong WHS Memorial Hospital (TW)
Corresponding author
TAI, CHING‐TAI
Venue
Journal of Cardiovascular Electrophysiology
Publisher
Wiley
Published
1999-09
Volume
10
Issue
9
Pages
1180-1187
ISSN
  • 1045-3873 (ISSN-L)
  • 1540-8167
OpenAlex
W1984529213
Cited by
60
References
22
Citations by year
2024: 1 · 2022: 1 · 2020: 3 · 2019: 1 · 2016: 3 · 2015: 2 · 2012: 3
FWCI
3.16
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Cardiovascular Electrophysiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
atrial fibrillation, amiodarone, propafenone, antiarrhythmic drugs, radiofrequency ablation, atrial enlargement, risk factors, sinus rhythm maintenance
MeSH terms
Aged, Aged, 80 and over, Amiodarone, Anti-Arrhythmia Agents, Atrial Fibrillation, Atrial Flutter, Electrocardiography, Female, Humans, Male, Middle Aged, Propafenone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review